Stockhead on MSN10d
AdAlta prioritises ‘East to West’ cellular immunotherapy strategy to drive value creationAdAlta (ASX:1AD) is bringing cellular immunotherapy products from Asian to western markets to drive value creation.
Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.
New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...
News Medical on MSN8d
Microglia reprogramming offers novel strategy to combat melanoma brain metastasesThe team collaborated with the Cellular Plasticity ... (both in Madrid), who provided patient samples. More information: ...
Cancer cells cripple immune cells by donating their damaged mitochondria, hindering the immune response and fostering tumour ...
Immunotherapy has changed the way physicians treat cancer patients. This approach to therapy targets the immune system to redirect cells toward the tumor. | Immunology ...
News Medical on MSN4d
New mechanism of immune evasion discovered in cancer cellsThe immune system plays a key role in detecting and destroying cancer cells. Cancer immunotherapy works by programming immune cells to recognize and eliminate cancer cells.
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback